TAYLOR BARRETT: Open Payments
NPI 1861965493 · GADSDEN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,138 in 183 payments from 15 companies in 2025. Trend: 2023 $3,044 · 2024 $3,789 · 2025 $3,138
Food & beverage: $3,138
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 38 | $571 |
| Alkermes, Inc. | 19 | $476 |
| Otsuka America Pharmaceutical, Inc. | 23 | $416 |
| Supernus Pharmaceuticals, Inc. | 15 | $295 |
| Tris Pharma Inc | 17 | $241 |
| ABBVIE INC. | 14 | $224 |
| Collegium Pharmaceutical, Inc. | 12 | $160 |
| Corium, LLC | 9 | $160 |
| Axsome Therapeutics, Inc. | 13 | $157 |
| Lundbeck LLC | 5 | $118 |
Products named: CAPLYTA, REXULTI, ARISTADA, Qelbree, Dyanavel XR, VRAYLAR, Jornay PM, Azstarys.
Industry payments across AL — which companies pay providers there.
